期刊文献+

自拟密骨培元饮联合鲑鱼降钙素及碳酸钙治疗原发性骨质疏松症临床研究 被引量:7

Clinical Study on the Treatment of Primary Osteoporosis Patients by Self- made Migu Peiyuan Decoction Combined with Salmon Calcitonin and Calcium Carbonate
下载PDF
导出
摘要 目的自拟探讨密骨培元饮联合鲑鱼降钙素及碳酸钙治疗原发性骨质疏松症的临床疗效。方法选取本院120例原发性骨质疏松症患者,随机分为治疗组(60例)和对照组(60例),对照组采用鲑鱼降钙素及碳酸钙治疗,治疗组采用密骨培元饮联合鲑鱼降钙素及碳酸钙治疗。结果治疗后,2组的VAS评分值和骨密度值均有明显改善(P<0.05);且组间对比,以治疗组进步更为显著(P<0.05);治疗组的疗效明显优于对照组(P<0.05)。结论密骨培元饮联合鲑鱼降钙素及碳酸钙治疗原发性骨质疏松症能产生相互协同和增效作用,具有更好的疗效,其协同和增效的具体机制以及如何进一步优化治疗方案,以最小的剂量达到最优的治疗效果有待进一步研究与观察。 Objective: To study the clinical effect of selfmade Migu Peiyuan Decoction combined with salmon calcitonin and calcium carbonate on the treatment of primary osteoporosis patients. Methods: 120 patients were randomly divided into a treatment group and a control group, 60 per group. The control group was treated with salmon calcitonin and calcium carbonate while the treatment group was treated with self - made Migu Peiyuan Decoction combined with salmon calcitonin and calcium carbonate. Results : VAS scores and BMD of the two groups showed significant improvement ( P 〈 0.05 ) after the treatment and the contrast between the two groups showed that the treatment group improved more significantly ( P 〈 0. 05 ). The effectiveness of the treatment group was significantly better than that of the control group ( P 〈 0.05 ). Conclusion : Migu Peiyuan Decoction combined with salmon calcitonin and calcium carbonate can produce mutual collaboration and synergies and therefore has a better effect. Its specific mechanism of the collaboration and synergies and how to further optimize treatment programs with a minimum dose to achieve optimal therapeutic effect needs further study and observation.
出处 《云南中医中药杂志》 2014年第6期15-18,共4页 Yunnan Journal of Traditional Chinese Medicine and Materia Medica
关键词 密骨培元饮 原发性骨质疏松症 视觉模拟评分 骨密度 Migu Peiyuan Decoction, primary osteoporosis, visual analog scale, bone density
  • 相关文献

参考文献9

二级参考文献54

共引文献1341

同被引文献106

  • 1彭松林,吕维加,夏仁云,方煌,李锋,陆瓞骥.锶盐对骨质疏松大鼠骨微结构的影响[J].中国骨与关节外科,2008,1(1):40-43. 被引量:2
  • 2耿力,姚珍薇.OPG/RANKL/RANK系统与绝经后骨质疏松症的关系[J].重庆医学,2007,36(9):878-879. 被引量:3
  • 3张兆川,鹿均先,熊传芝.锶盐在治疗骨质疏松症中的作用[J].现代医学,2007,35(1):64-66. 被引量:8
  • 4周力学.绝经后骨质疏松症[J].新医学,2007,38(9):611-613. 被引量:13
  • 5Teede HJ.The menopause and HRT.Hormone replace- ment therapy,cardiovascular and cerebrovascular disease [ J ] .Best Pract Res Clin Endocrinol Me- tab,2003,17 ( 1 ) :73-90.
  • 6Vickers MR,Martin J,Meade TW, et al.The Women's in- ternational study of long-duration oestrogen after meno- pause ( WISDOM ) :a randomised controlled trial [ J ]. BMC Womens Health,2007 ( 7 ) :2.
  • 7孟洁,王新英.绝经后骨质疏松症西药治疗进展[J].中国综合临床,2013,29(z1):168-170.
  • 8McClung MR.The menopause and HRT.Prevention and management of osteoporosis [J].Best Pract Res Clin Endocrinol Metab,2003,17 ( 1 ) :53-71.
  • 9Alvarez A,Kremer R, Weiss DR, et al.Response of post- poliomyelitis patients to bisphosphonate treatment [ J ].PM R,2010,2 ( 12 ) :1094-1103.
  • 10Black DM,Bilezikian JP,Greenspan SL,et al.Improved adherence with PTH ( 1-84 ) in an extension trial for 24 months results in enhanced BMD gains in the treat- ment of postmenopausal women with osteoporosis [J]. Osteoporos Int,2013,24 ( 4 ) :1503-1511.

引证文献7

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部